评估和治疗异常的非自愿运动:一个临床集中叙事审查
Aldis Petriceks1, Chirag M Vyas, Shreedhar Paudel
1From Harvard Medical School, Boston, MA (Mr. Petriceks, Drs. Vyas, Paudel, Donovan, Van Alphen, and Stern); Department of Psychiatry, Massachusetts General Hospital, Boston, MA (Drs. Vyas, Paudel, Donovan, Van Alphen, and Stern); Atrius Health, Boston, MA (Dr. Van Alphen).
Harvard review of psychiatry
|March 7, 2024
概括
异常非自愿运动 (AIMs) 是需要使用诸如异常非自愿运动量表 (AIMS) 等工具进行准确评估的不受控制的运动. 综合性,多学科的护理对于管理AIM和改善患者福祉至关重要.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 由于复杂的神经生物学,异常的非自愿运动 (AIM) 构成了诊断挑战.
- AIMs影响患者在所有生命阶段,需要有效的临床管理策略.
研究的目的:
- 分类和描述各种类型的AIM.
- 突出验证的评估工具对AIMs的重要性.
- 讨论AIM目前的治疗选择和综合护理策略.
主要方法:
- 对AIMs的叙述性审查.
- 对AIM类型和神经生物学方面进行分类.
- 强调验证的测量尺度,如异常非自愿运动尺度 (AIMS).
主要成果:
- 准确量化AIM严重程度对于有效管理至关重要.
- 治疗的有效性可能受到副作用的限制.
- 多学科,以患者为中心的护理对于整体管理至关重要.
结论:
- 使用像AIMS这样的验证规模,可以对AIM进行客观评估和跟踪.
- 需要量身定制的治疗和持续的支持来管理AIMs的多方面的影响.
- 综合护理提高了患者的福祉和生活质量.
相关概念视频
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K